Search Results - "Kuchta, Kristine M."

Refine Results
  1. 1
  2. 2

    Impact of Surgical Delay on Tumor Upstaging and Outcomes in Estrogen Receptor–Negative Ductal Carcinoma in Situ Patients by Deliere, Amanda E, Kuchta, Kristine M, Pesce, Catherine E, Kopkash, Katherine A, Yao, Katharine A

    “…BACKGROUNDThe delay of elective surgeries by the coronavirus 2019 (COVID-19) pandemic prompted concern among surgeons to delay estrogen receptor (ER)-negative…”
    Get full text
    Journal Article
  3. 3

    Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival by Holoubek, Simon A., Yan, Huan, Khokar, Amna H., Kuchta, Kristine M., Winchester, David J., Prinz, Richard A., Moo-Young, Tricia A.

    Published in Surgery (01-01-2020)
    “…This study compares pathologic features and overall survival of classic versus aggressive variants of papillary thyroid microcarcinoma (PMTC). Patients ≥18…”
    Get full text
    Journal Article
  4. 4

    Parathyroidectomy is Safe in Elderly Patients: A National Surgical Quality Improvement Program Study by Khokar, Amna M., Kuchta, Kristine M., Moo-Young, Tricia A., Winchester, David J., Prinz, Richard A.

    Published in World journal of surgery (01-02-2020)
    “…Background With increasing age, the incidence of hyperparathyroidism is increased. This study evaluates parathyroidectomy outcomes in elderly patients. Methods…”
    Get full text
    Journal Article
  5. 5

    Increasing trend of bilateral neck exploration in primary hyperparathyroidism by Khokar, Amna M., Kuchta, Kristine M., Moo-Young, Tricia A., Winchester, David J., Prinz, Richard A.

    Published in The American journal of surgery (01-03-2020)
    “…Bilateral neck exploration was the standard operation for primary hyperparathyroidism. With improvements in preoperative localization and use of intraoperative…”
    Get full text
    Journal Article
  6. 6

    Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm by Holoubek, Simon A., MacKinney, Erin C., Khokar, Amna M., Kuchta, Kristine M., Winchester, David J., Prinz, Richard A., Moo-Young, Tricia A.

    Published in Surgery (01-01-2022)
    “…Tall cell and diffuse sclerosing variants of papillary thyroid cancer are associated with aggressive features. Radioactive iodine after total thyroidectomy is…”
    Get full text
    Journal Article
  7. 7

    Treatment differences at high volume centers and low volume centers in non-metastatic and metastatic adrenocortical carcinoma by MacKinney, Erin C., Holoubek, Simon A., Khokar, Amna M., Kuchta, Kristine M., Moo-Young, Tricia A., Prinz, Richard A., Winchester, David J.

    Published in The American journal of surgery (01-03-2022)
    “…Adrenocortical carcinoma (ACC) is rare with poor survival. Do treatment and outcomes vary by volume? NCDB (2004–2017) was searched for patients with ACC…”
    Get full text
    Journal Article
  8. 8

    Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer by MacKinney, Erin C., Kuchta, Kristine M., Winchester, David J., Khokar, Amna M., Holoubek, Simon A., Moo-Young, Tricia A., Prinz, Richard A.

    Published in Surgery (01-01-2022)
    “…We examine whether surgery extent and radiation administration affect overall survival for cT2N0M0 classic papillary thyroid cancer according to age and sex…”
    Get full text
    Journal Article
  9. 9

    Treatment Differences for Adrenocortical Carcinoma by Race and Insurance Status by Holoubek, Simon A., MacKinney, Erin C., Khokar, Amna M., Kuchta, Kristine M., Winchester, David J., Prinz, Richard A., Moo-Young, Tricia A.

    Published in The Journal of surgical research (01-12-2022)
    “…To determine if treatment and clinical outcomes of adrenocortical carcinoma (ACC) vary by race and insurance status. ACC patients from the National Cancer…”
    Get full text
    Journal Article
  10. 10

    The Effect of Commonly Used Local Anesthetic on Bacterial Growth by Callahan, Zachary M., Roberts, Amity L., Christopher, Adrienne N., Gadomski, Stephen P., Kuchta, Kristine M., Costanzo, Caitlyn M., Phillips, Benjamin R., Isenberg, Gerald A., Goldstein, Scott D.

    Published in The Journal of surgical research (01-06-2022)
    “…Liposomal bupivacaine (LB) has emerged as a superior form of local anesthetic across numerous surgical subspecialties. The purpose of this study is to evaluate…”
    Get full text
    Journal Article
  11. 11

    Survival with Follicular and Hurthle Cell Microcarcinoma Compared to Papillary Thyroid Microcarcinoma: A Population Study of 84,532 Patients by Khokar, Amna M., Holoubek, Simon A., Kuchta, Kristine M., Winchester, David J., Prinz, Richard A., Moo-Young, Tricia A.

    Published in World journal of surgery (01-02-2020)
    “…Background This study compares survival in patients with the rare subtypes of follicular (FTmC) and Hurthle cell (HCmC) microcarcinoma compared to that of…”
    Get full text
    Journal Article
  12. 12

    Trends in nonoperative management of papillary thyroid microcarcinoma by Holoubek, Simon A., Yan, Huan, Kuchta, Kristine M., Winchester, David J., Moo‐Young, Tricia A., Prinz, Richard A.

    Published in Journal of surgical oncology (01-05-2020)
    “…Background In 2010, a Japanese trial of nonoperative management for papillary thyroid microcarcinomas (PTmC) was published. This study determines if the…”
    Get full text
    Journal Article
  13. 13

    Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? by Suss, Nicholas R., Talamonti, Mark S., Bryan, Darren S., Wang, Chi-Hsiung, Kuchta, Kristine M., Stocker, Susan J., Bentrem, David J., Roggin, Kevin K., Winchester, David J., Marsh, Robert, Prinz, Richard A., Murad, Faris M., Baker, Marshall S.

    Published in Surgery (01-05-2018)
    “…The benefit of adding external beam radiation to adjuvant chemotherapy in patients that have undergone a margin positive resection for early stage, pancreatic…”
    Get full text
    Journal Article
  14. 14

    Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer by Krantz, Seth B., Zeeshan, Kanwal, Kuchta, Kristine M., Hensing, Thomas A., Mangold, Kathy A., Zheng, S. Lilly, Xu, Jianfeng

    Published in JTCVS open (01-12-2022)
    “…To determine the frequency of pathogenic mutations in high-penetrance genes (HPGs) in patients with non–small cell lung cancer (NSCLC) and identify whether…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancerCentral MessagePerspective by Seth B. Krantz, MD, Kanwal Zeeshan, MBBS, Kristine M. Kuchta, MS, Thomas A. Hensing, MD, Kathy A. Mangold, PhD, S. Lilly Zheng, MD, Jianfeng Xu, MD, DrPH

    Published in JTCVS open (01-12-2022)
    “…Objective: To determine the frequency of pathogenic mutations in high-penetrance genes (HPGs) in patients with non–small cell lung cancer (NSCLC) and identify…”
    Get full text
    Journal Article
  20. 20

    Impact of Perioperative Infection on Cancer-Specific Survival after Nephrectomy for Renal Cell Carcinoma by Tallman, Jacob E., BA, Pearce, Shane M., MD, Kuchta, Kristine, MS, Helfand, Brian T., MD PhD, Eggener, Scott E., MD

    Published in The Journal of urology (01-11-2017)
    “…Abstract Introduction Several case reports have documented rare spontaneous cancer regression following systemic infections. Immune-related targeted therapies…”
    Get full text
    Journal Article